Cancer Family
Childhood Neoplasm
CI-CAN-00000009Explore in graph →
PediatricNon-malignant313 active trials1 approved drugs68 evidence items
- NCIt
- C6283
Loading cancer entity…
Cancer Family
CI-CAN-00000009Explore in graph →
Clinical trials
1,504 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01353300 | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | completed | — | 31 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
| NCT00006348 | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment | completed | Phase 3 | 100 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 |
| clinicaltrials |
| NCT00003852 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | terminated | Phase 2 | 45 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT01036009 | A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies | completed | Phase 2 | 43 | University of California, San FranciscoOTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00049023 | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | completed | Phase 1 | 27 | O'Dorisio, M SOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01645436 | Physical Activity in Pediatric Cancer (PAPEC)(PAPEC) | completed | N/A | 49 | Universidad Europea de MadridOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02031965 | Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery | terminated | Phase 1 | 2 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | May 30, 2016 | clinicaltrials |
| NCT01076569 | Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia | completed | — | 250 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01118078 | Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor | completed | — | 185 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01496573 | Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma | completed | — | 77 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01642121 | Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia | completed | — | 20 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01024127 | Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia | completed | — | 2,500 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01150669 | Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia | completed | — | 18 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01336881 | Biomarkers in Tissue Samples From Young Patients With Liver Cancer | completed | — | 99 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01407744 | Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial | completed | — | 80 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01433224 | Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression | completed | — | 90 | Children's Oncology GroupNETWORK | 0 | May 18, 2016 | clinicaltrials |
| NCT01540578 | Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia | completed | — | 70 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01625143 | Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia | completed | — | 40 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01642069 | Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia | completed | — | 100 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01668095 | Biomarkers in Patients With Advanced Rhabdomyosarcoma | completed | — | 10 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT00720174 | Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | May 17, 2016 | clinicaltrials |
| NCT01146210 | Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia | completed | — | 20 | Children's Oncology GroupNETWORK | 1 | May 17, 2016 | clinicaltrials |
| NCT01567046 | Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas | completed | — | 70 | Children's Oncology GroupNETWORK | 1 | May 17, 2016 | clinicaltrials |
| NCT00898404 | Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate | completed | — | 150 | Children's Oncology GroupNETWORK | 1 | May 11, 2016 | clinicaltrials |
| NCT01742481 | Study to Education Childhood Cancer Survivors About Survivorship Care(SPEAC) | completed | N/A | 50 | University of Illinois at ChicagoOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01056614 | Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies | completed | Phase 2 | 23 | Fred Hutchinson Cancer CenterOTHER | 1 | May 6, 2016 | clinicaltrials |
| NCT01803672 | Effectiveness of an Integrated Programme in Promoting the Regular Physical Activity Among Childhood Cancer Survivors | completed | N/A | 71 | The University of Hong KongOTHER | 1 | Apr 26, 2016 | clinicaltrials |
| NCT00675467 | Palliative Care and Symptom Management for the Pediatric Oncology Patient | completed | — | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 8, 2016 | clinicaltrials |
| NCT00939380 | Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial(P-SCIP) | completed | N/A | 212 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00326664 | AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Mar 7, 2016 | clinicaltrials |
| NCT02444884 | MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors | completed | Phase 1 | 54 | Children's Oncology GroupNETWORK | 0 | Feb 9, 2016 | clinicaltrials |
| NCT01239316 | Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2016 | clinicaltrials |
| NCT01783418 | Mindfulness-based Intervention for Teenagers With Cancer | completed | N/A | 15 | St. Justine's HospitalOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT01748721 | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT02533895 | Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood | completed | Phase 1 | 67 | Activartis BiotechINDUSTRY | 1 | Dec 29, 2015 | clinicaltrials |
| NCT00084838 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | completed | Phase 2 | 25 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
| NCT00024258 | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors | completed | Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT02000986 | Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors | withdrawn | N/A | 0 | Virginia Commonwealth UniversityOTHER | 0 | Nov 20, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00890435 | Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial | completed | — | 53 | Children's Oncology GroupNETWORK | 0 | Oct 21, 2015 | clinicaltrials |
| NCT02032121 | Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors | completed | N/A | 6 | University of MiamiOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT01462695 | Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 3 | Aug 27, 2015 | clinicaltrials |
| NCT01959477 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | completed | Early Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02509234 | Trabectedin and Irinotecan for Refractory Pediatric Sarcomas(TrIPReSarc) | unknown | — | 30 | Technical University of MunichOTHER | 0 | Jul 27, 2015 | clinicaltrials |
| NCT01403415 | Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 2 | Jul 10, 2015 | clinicaltrials |
| NCT01725191 | Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 2 | Jul 2, 2015 | clinicaltrials |
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | withdrawn | — | 0 | Rutgers, The State University of New JerseyOTHER | 1 | May 29, 2015 | clinicaltrials |
| NCT01861990 | Valproic Acid in Childhood Progressive Brain Tumors | withdrawn | Phase 1 | 0 | Medical University of South CarolinaOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT01623856 | Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients | completed | — | 483 | Children's Oncology GroupNETWORK | 1 | May 7, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jul 11, 2016source: clinicaltrials